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Background: Campylobacter jejuni causes acute disease characterized by severe diarrhea containing blood and
leukocytes, fever, and abdominal cramping. Disease caused by C. jejuni is dependent on numerous bacterial and
host factors. C. jejuni invasion of the intestinal epithelial cells is seen in both clinical samples and animal models
indicating that host cell invasion is, in part, necessary for disease. C. jejuni utilizes a flagellar Type III Secretion System
(T3SS) to deliver the Campylobacter invasion antigens (Cia) to host cells. The Cia proteins modulate host cell
signaling leading to actin cytoskeleton rearrangement necessary for C. jejuni host cell invasion, and are required for
the development of disease.
Results: This study was based on the hypothesis that the C. jejuni CiaD effector protein mediates Erk 1/2 dependent
cytoskeleton rearrangement. We showed that CiaD was required for the maximal phosphorylation of Erk 1/2 by
performing an immunoblot with a p-Erk 1/2 specific antibody and that Erk 1/2 participates in C. jejuni invasion of host
cells by performing the gentamicin protection assay in the presence and absence of the PD98059 (a potent inhibitor of
Erk 1/2 activation). CiaD was also found to be required for the maximal phosphorylation of cortactin S405 and S418, as
judged by immunoblot analysis. The response of human INT 407 epithelial cells to infection with C. jejuni was evaluated
by confocal microscopy and scanning electron microscopy to determine the extent of membrane ruffling. This analysis
revealed that CiaD, Erk 1/2, and cortactin participate in C. jejuni-induced membrane ruffling. Finally, cortactin and
N-WASP were found to be involved in C. jejuni invasion of host cells using siRNA to N-WASP, and siRNA to cortactin,
coupled with the gentamicin protection assay.
Conclusion: We conclude that CiaD is involved in the activation of Erk 1/2 and that activated Erk 1/2 facilitates
C. jejuni invasion by phosphorylation of cortactin on serine 405 and 418. This is the first time that cortactin and
N-WASP have been shown to be involved in C. jejuni invasion of host cells. These data also provide a mechanistic basis
for the requirement of Erk 1/2 in C. jejuni-mediated cytoskeletal rearrangement.
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Campylobacter jejuni uses the flagellum as a Type III Se-
cretion System (T3SS). A subset of proteins are exported
from the flagellum and delivered to the cytosol of host
cells where they modify host cell signaling events to pro-
mote bacterial invasion. Here we report that C. jejuni,
which is the leading bacterial cause of food-borne dis-
ease worldwide, usurps the host cell signaling proteins
Erk 1/2 and cortactin. We show that the C. jejuni CiaD* Correspondence: konkel@vetmed.wsu.edu
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distribution, and reproduction in any mediumprotein is required for the invasion of host cells and for
the activation of Erk 1/2 (a host cell kinase) and cortac-
tin (a cellular scaffolding protein). The characterization
of a virulence protein and the identification of a novel
host cell signaling pathway exploited by C. jejuni pro-
vides a significant advancement in the understanding of
C. jejuni pathogenesis.
Background
Cortactin is an actin-binding protein that plays an integral
role in the regulation and dynamics of the actin cytoskel-
eton. Cortactin has emerged as a key cellular protein that
microbes readily subvert during the establishment of in-
fection [1]. To date, cortactin has been demonstrated toed Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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bacterial pathogens. While several pathogens, including
Shigella, Neisseria, Rickettsia, Chlamydia, Staphylococcus,
Listeria, Helicobacter, Escherichia, and Coxiella, require
Src-mediated tyrosine phosphorylation of cortactin for host
cell invasion, the mechanism of cortactin activation has
only been partially elucidated or is, in most instances, not
known [1-8]. The role of various actin cytoskeleton regula-
tors, including Erk 1/2 and cortactin, in C. jejuni invasion
has not been elucidated.
Campylobacter jejuni is a Gram-negative bacterial
pathogen that causes acute disease characterized by se-
vere diarrhea. C. jejuni causes ~1.4 to 2.3 million cases of
gastroenteritis in the United States each year [9]. Guillain–
Barré syndrome (GBS), an autoimmune disease affecting
the peripheral nervous system, can be a possible sequelae
associated with certain strains of C. jejuni [10]. Motility,
adherence, invasion, intracellular survival, and toxin pro-
duction have all been shown to contribute to the severity
of C. jejuni-mediated disease, illustrating the fact that dis-
ease is a multifactorial process [11-16].
Maximal cell invasion requires the Campylobacter in-
vasion antigens (Cia) [14]. The Cia proteins are exported
from the bacterium’s flagellar Type III Secretion System
(T3SS) and are delivered to the target host cell, where
they presumably modify host cell regulatory proteins to
promote C. jejuni-host cell entry and intracellular survival.
Co-culture of C. jejuni with either host cells or host-like
conditions results in increased expression of the genes en-
coding the Cia proteins [17,18]. To date, four Cia proteins
have been identified, designated CiaB, CiaC, CiaD, and
CiaI [11,16,19,20]. The importance of the Cia proteins in
campylobacteriosis has been demonstrated using in vivo
studies with a ciaB mutant, which is deficient in the secre-
tion of all of the Cia proteins [15]. Piglets inoculated with
a C. jejuni wild-type strain develop severe diarrhea within
24 hours of infection and exhibited major histological ab-
normalities, such as villus blunting and production of exu-
dates in the lumen. In contrast, piglets inoculated with the
ciaB mutant did not developed diarrhea until 3 days post
infection and only exhibited minor histological lesions.
Piglets inoculated with a ciaB mutant harboring a wild-
type copy of the ciaB gene exhibited clinical signs of
disease similar to piglets inoculated with the C. jejuni
wild-type strain [21]. Given that the Cia proteins contrib-
ute to the development of C. jejuni-mediated enteritis,
additional work is warranted to further dissect the func-
tions of these proteins.
We recently identified a secreted protein, which we
termed CiaD (Cj0788), that is exported from the flagel-
lum and delivered to the cytosol of host cells. We found
that CiaD activates the host cell kinases p38 and Erk 1/2,
resulting in the secretion of interleukin-8 (IL-8) from host
cells. Similarly, we found that CiaD-mediated activation ofp38 and Erk 1/2 are required for maximal invasion of host
cells by C. jejuni. CiaD function within host cells is
dependent on a mitogen-activated protein (MAP) kinase-
docking motif. Finally, CiaD was found to contribute to the
development of disease, as evidenced by gross pathology
and histopathology of tissues from IL-10 knockout mice
inoculated with a C. jejuni wild-type strain, ciaD mutant,
and ciaD complemented isolate [22]. While it is known
that CiaD contributes to C. jejuni invasion of host cells,
the details of the molecular mechanisms of C. jejuni-host
cell invasion are incomplete.
The goal of this study was to determine the role of
CiaD in C. jejuni host cell invasion. We hypothesized
that the C. jejuni effector protein CiaD contributes to
bacterial invasion by stimulation of Erk 1/2 and the
phosphorylation of cortactin. We sought to identify the
role of Erk 1/2 and cortactin in C. jejuni invasion of host
cells. More specifically, we sought to determine if the
phosphorylation of cortactin is necessary for C. jejuni in-
vasion of host cells, and whether CiaD contributes to
the phosphorylation of cortactin.
Results
Erk 1/2 and the C. jejuni CiaD effector protein are required
for maximal invasion of human INT 407 epithelial cells
Experiments were initially performed to determine if CiaD
contributes to the activation of the Erk 1/2 signaling path-
way. Consistent with previous work [22], we found that
CiaD is required for maximal invasion of host INT 407
cells (Figure 1A) and contributes to the complete acti-
vation of the host cell kinase Erk 1/2 (Figure 1B). INT
407 cells are a human epithelial cell line [23]. To de-
termine if Erk 1/2 is involved in bacterial invasion, we
performed a gentamicin protection assay in the presence
of the MEK 1/2 inhibitor PD98059 (a potent inhibitor of
Erk 1/2 activation). Inhibition of Erk 1/2 activation was
found to significantly decrease the number of C. jejuni
internalized (Figure 1C), which is consistent with previ-
ous reports [24,25]. These results demonstrate that CiaD
and Erk 1/2 are necessary for maximal host cell invasion
by C. jejuni.
CiaD is required for host cell membrane ruffling
independent of Rho GTPase activation
Three Rho GTPases (i.e., Rho, Rac1, and Cdc42) are in-
volved in the regulation and dynamic rearrangement of
the actin cytoskeleton [26]. C. jejuni invasion of host cells
is accompanied by the activation of the Rho GTPases
Rac1 and Cdc42 [27,28]. Rac1 is involved in the formation
of lamellipodia and Cdc42 is involved in the formation
of filopodia [26]. We will refer to lamellipodia and filo-
podia extensions, which are membrane protrusions as-
sociated with reorganization of actin microfilaments, as
membrane ruffles throughout the manuscript. Experiments
Figure 1 CiaD and Erk 1/2 are required for maximal C. jejuni invasion. A. The C. jejuni ciaD mutant is deficient in maximal invasion of INT
407 cells. Invasion of INT 407 cells was assessed using a gentamicin protection assay as outlined in Methods. B. Maximal activation of Erk 1/2
requires CiaD. INT 407 cells were infected with the various isolates of C. jejuni for 45 min and cell lysates were evaluated via immunoblot. Blots
were probed with phospho-specific antibodies to Erk 1/2. All blots were stripped and re-probed with an α-Erk 1/2 antibody. Molecular mass size
standards, in kilodaltons (kDa), are indicated on the left. Densitometry of pErk 1/2 is shown as the ratio of p-Erk 1/2 to t-Erk 1/2 for each sample.
C. Erk 1/2 kinase activation is required for maximal bacterial invasion. PD98059, an inhibitor of Erk 1/2 activation, was added to INT 407 cells for
30 min prior to inoculation with a C. jejuni wild-type strain, and bacterial invasion was assessed. The asterisk indicates a significant reduction compared
to the value obtained for the C. jejuni wild-type strain, as judged by one-way ANOVA followed by post-hoc Dunnett’s analysis (P < 0.01). N.S. indicates
no significant difference. Results are shown as means ± SEM.
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cells upon infection with the C. jejuni wild-type strain,
ciaD mutant, and ciaD mutant expressing a wild-type copy
of ciaD in trans (ciaD complemented isolate), as well as
cells infected with a C. jejuni wild-type strain that had been
pretreated with the MEK 1/2 inhibitor PD98059 that
blocks Erk 1/2 activation. Representative scanning elec-
tron microscopy (SEM) images of the various C. jejuni
strains interacting with host INT 407 cells are shown in
Figure 2A1-9. Both flagellated and non-flagellated bac-
teria were visualized bound to the host cells. The obser-
vation of non-flagellated bacteria bound to the cells was
presumably due to the method of fixation, as all of thebacterial isolates were highly motile as judged by motility
assays (not shown). We observed that 28.8% ± 6.9% of
untreated and uninfected INT 407 cells had membrane
ruffling (Figure 2A1). In contrast, 57.9% ± 5.7% of INT
407 cells had pronounced membrane ruffling when inoc-
ulated with a C. jejuni wild-type strain (Figure 2A2).
Inoculation of INT 407 cells with the ciaD mutant
resulted in membrane ruffling in 45.1% ± 5.8% of the cells
(Figure 2A3), whereas inoculation of cells with the ciaD
complemented isolate resulted in membrane ruffling in
55.8% ± 5.6% of the cells (Figure 2A4). Pretreatment of
host cells with the Erk 1/2 inhibitor reduced the percent-
age of host cells with membrane ruffling to 42.4% ± 4.4%
Figure 2 CiaD induced host cell membrane ruffling is Rho GTPase independent. A. Representative scanning electron microscopy images of INT
407 cells; uninfected (Panel 1), infected with a C. jejuni wild-type strain (2 and 6), ciaD mutant (3 and 7), ciaD complemented isolate (4 and 8), and cells in-
fected with a C. jejuni wild-type strain that had been pretreated with PD98059, an inhibitor of Erk 1/2 activation (5 and 9). Arrows in higher magnification
images show bacteria in direct contact with host cells (6, 7, 8, and 9). INT 407 cells infected with the C. jejuni wild-type strain or the ciaD complemented
isolate show extensive membrane ruffling (6 and 8), and INT 407 cells infected with the ciaD mutant or cells infected with a C. jejuni wild-type strain that
had been pretreated with PD98059 display little host cell membrane ruffling (7 and 9). Images are shown at a magnification of 7,000× with a 10 μM scale
bar (1–5), and 50,000× with a 2 μM scale bar (6–9). Boxes indicate the area of the INT 407 cell that is shown in the 50,000× panel. Indicated within each
panel is the percent of host cell that display membrane ruffling. B. Rac1 activation in host cells infected with C. jejuni. Whole cell lysates were
processed after 15 min of infection and analyzed for activated Rac1 by G-LISA™. The mean ± SEM of total active Rac1 is indicated in relative op-
tical density. C. Cdc42 activation in host cells infected with the various C. jejuni strains was assessed by G-LISA™. The mean ± SEM of total active Cdc42 is
indicated in relative optical density. The asterisks indicate a significant difference (P< 0.01) in the level of Rac1 or Cdc42 activation in cells infected with
the C. jejuni wild-type strain, as judged by one-way ANOVA followed by post-hoc Dunnett’s analysis. N.S. indicates no significant difference.
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imal membrane ruffling of host INT 407 cells requires
CiaD and Erk 1/2.
Given that the C. jejuni ciaD mutant was found to be
deficient in stimulating membrane ruffling, we investi-
gated whether there was a defect in Rho GTPase activa-
tion. The ciaD mutant exhibited normal Rac1 (Figure 2B)
and Cdc42 (Figure 2C) activity when compared to the
C. jejuni wild-type strain, as determined by G-LISA™.
The fact that the activation levels of the Rho GTPases
are not changing in the C. jejuni ciaD mutant was in-
teresting, as there were clear reductions in bacterial
invasion and host cell membrane ruffling. These dataindicate that activated Rac1 and Cdc42 require assembly
and/or activation of scaffold or accessory proteins to fa-
cilitate lamellipodia and filopodia extensions. Given the
complexity of the C. jejuni-mediated invasion complex,
we chose to focus on the role of CiaD-mediated Erk 1/2
activation and the potential targets of Erk 1/2 that par-
ticipate in membrane ruffling.
CiaD mediated Erk 1/2 activation is required for cortactin
serine phosphorylation
Experiments were performed to determine if Erk 1/2 par-
ticipates in transcriptional regulation of genes and/or ac-
tivation of cytosolic signaling proteins necessary for actin
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invasion and membrane ruffling. We first assessed the
role of Erk 1/2 mediated transcriptional regulation in
C. jejuni invasion of host cells. To prevent Erk 1/2 medi-
ated transcriptional activation in response to infection with
C. jejuni, host INT 407 cells were pre-treated with 5,6-
dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). DRB
inhibits Cdk-activating kinase (a TFIIH-associated kinase),
thereby preventing transcription by RNA polymerase II
[29]. To determine the concentration of DRB necessary to
inhibit transcription, cells were pre-treated with different
concentrations of DRB and the secretion of interleukin-8
(IL-8) from host cells was determined. The host cell che-
mokine IL-8 is transcribed, translated, and secreted fromFigure 3 Erk 1/2 is necessary for cytosolic signaling required for max
with C. jejuni incubated for 6 h, and IL-8 quantified using an IL-8 ELISA. The tran
was added to INT 407 cells for 30 min prior to infection with a C. jejuni wild-typ
were infected with C. jejuni and invasion was assessed. C. CiaD is required for s
various C. jejuni strains and cellular lysates were prepared. Blots were probed w
re-probed with an α-cortactin antibody. Densitometry of p-cortactin is shown a
D. Erk 1/2 is required for serine phosphorylation of cortactin. INT 407 cells were
with a C. jejuni wild-type strain. Blots were probed with a phospho-specific ant
antibody. Molecular masses, in kilodaltons (kDa), are indicated on the left. The a
obtained for the C. jejuni wild-type strain, as judged by one-way ANOVA followhost cells in response to numerous bacterial pathogens, in-
cluding C. jejuni [30-35]. Pretreatment of INT 407 cells
with DRB resulted in a reduction in the amount of IL-8
in supernatants from C. jejuni infected cells (Figure 3A),
suggesting that DRB effectively blocks the transcription of
IL-8. However, pretreatment of INT 407 cells with DRB re-
sulted in normal C. jejuni invasion of host cells (Figure 3B).
These results suggest that Erk 1/2 mediated transcriptional
regulation is not involved in host cell actin cytoskeleton re-
arrangement necessary for C. jejuni host cell invasion.
Given that Erk 1/2 mediated transcriptional regulation
is not required for cytoskeleton rearrangement, we per-
formed experiments to determine if cytosolic signaling
mediated by Erk 1/2 was altered or impaired. We chose toimal C. jejuni invasion of host cell. A. INT 407 cells were infected
scription inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)
e strain. B. Transcription is not required for C. jejuni invasion. INT 407 cells
erine phosphorylation of cortactin. INT 407 cells were infected with the
ith phospho-specific antibodies to cortactin. The blot was stripped and
s the ratio of p-cortactin to total cortactin (t-cortactin) for each sample.
pre-treated with PD98059, an inhibitor of Erk 1/2 activation, and infected
ibody to cortactin. The blot was stripped and re-probed with an α-tubulin
sterisks indicate a significant difference (P < 0.01) compared to the value
ed by post-hoc Dunnett’s analysis. N.S. indicates no significant difference.
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cytosolic actin binding protein cortactin, a known target
of Erk 1/2 and a component of the actin polymerization
and nucleation complex [36]. In contrast to infection of
INT 407 cells with a C. jejuni wild-type strain, the C.
jejuni ciaD mutant was deficient in maximal phosphoryl-
ation of cortactin at the Erk 1/2 phosphorylation sites
S405 and S418, as judged by immunoblot analysis with the
S418 and S405 phospho-specific antibodies to cortactin
(Figure 3C). INT 407 cells infected with the C. jejuni ciaD
complemented isolate restored the phosphorylation of
cortactin to levels indistinguishable from infection with a
C. jejuni wild-type strain (Figure 3C). This finding indi-
cates that CiaD mediated activation of Erk 1/2 leads to the
phosphorylation of cortactin on serine residues. Consist-
ent with the fact that CiaD mediates Erk 1/2 activation
and Erk 1/2 mediates the phosphorylation of cortactin on
S405 and S418, we found that pretreatment of INT 407
cells with the MEK 1/2 inhibitor PD98059 reduced phos-
phorylation of cortactin on S418 in response to C. jejuni
infection, similar to the level observed in uninfected cells
(Figure 3D). The inhibition of cortactin serine phosphoryl-
ation by treatment of cells with PD98059 is in agreement
with published data [37]. However, this is the first report
showing that cortactin becomes activated in response to
C. jejuni infection. Given that CiaD is required for max-
imal cortactin activation, we assessed the role of cortactin
phosphorylation in C. jejuni invasion of host cells.
Cortactin serine phosphorylation is required for
maximal invasion
To determine if cortactin is required for C. jejuni invasion
of host cells, we used small interfering RNA (siRNA) to
knockdown cortactin and siRNA to knockdown the down-
stream complex protein N-WASP. N-WASP is a known
component of the actin nucleation and polymerization
complex and is necessary for the complete activation of
Arp 2/3. More specifically, serine phosphorylation of cor-
tactin leads to the recruitment of N-WASP, activation of
Arp 2/3, and actin remodeling [36]. INT 407 cells were
transfected with siRNA to cortactin or siRNA to N-WASP,
and C. jejuni invasion of host cells was evaluated using the
gentamicin protection assay. The knockdown of cortactin
resulted in a significant reduction in the number of
C. jejuni internalized by host cells (Figure 4A). The knock-
down of N-WASP also significantly reduced the amount
of internalized C. jejuni (Figure 4A). Effective knockdown
of cortactin (60.6% ± 3.3% knockdown) and N-WASP
(67.8% ± 1.1% knockdown) was demonstrated by immuno-
blot analysis (Figure 4B). These data support the proposal
that cortactin and N-WASP are necessary for maximal
C. jejuni invasion of host cells.
To evaluate the specific contribution of Erk 1/2 phos-
phorylation of cortactin at S405 and S418 in C. jejunihost cell invasion, phosphorylation null constructs of
cortactin were utilized and the gentamicin protection
assay was performed. INT 407 cells were transfected
with cortactin-EGFP phosphorylation null constructs
with the following mutations: S405A, S418A, and S405/
418A (double serine mutant). The contributions of c-Src
(tyrosine) phosphorylation of cortactin were also evaluated,
as c-Src phosphorylation of cortactin is known to be im-
portant for the invasion of other pathogens [2,3,5]. INT
407 cells were transfected with cortactin-EGFP Y421F and
Y421/470/486 F (triple tyrosine mutant) mutant constructs
to evaluate the role of c-Src phosphorylation of cortactin.
We found that both cortactin serine and tyrosine phos-
phorylation are required for maximal invasion of host cells
by C. jejuni, as judged by the gentamicin protection assay
(Figure 4C). Equal expression of the cortactin-EGFP phos-
phorylation null constructs was confirmed via immunoblot
analysis (Figure 4D). In support of the finding that tyrosine
phosphorylation of cortactin is required for C. jejuni inva-
sion, inhibition of the upstream kinase c-Src with the in-
hibitor PP2 prevented C. jejuni internalization (Additional
file 1: Figure S1). This is the first report to our knowledge
demonstrating that serine phosphorylation of cortactin by
Erk 1/2 and tyrosine phosphorylation of cortactin by c-Src
are required for C. jejuni invasion of host cells. Based on
these results, we hypothesized that cortactin and the serine
phosphorylation of cortactin are necessary for C. jejuni-
induced membrane ruffling.Cortactin serine phosphorylation is required for host cell
membrane ruffling
To evaluate the role of cortactin activation by CiaD
in C. jejuni-mediated host cell membrane ruffling, we
utilized EGFP-tagged cortactin to visualize membrane
ruffling. INT 407 cells, which had been transfected with a
cortactin-EGFP construct, were infected with the C. jejuni
wild-type strain, ciaD mutant, and the ciaD comple-
mented isolate and the cells examined by confocal
microscopy. Uninfected cells transfected with cortactin-
EGFP exhibited diffuse cortactin localization with no
distinct membrane ruffling of cell borders (Additional
file 2: Figure S2 A-D). However, infection with the C. jejuni
wild-type stain resulted in membrane ruffling (Additional
file 2: Figure S2 E-H). In contrast, the C. jejuni ciaD mu-
tant was deficient in membrane ruffling and exhibited dif-
fuse cortactin localization similar to that of uninfected cells
(Additional file 2: Figure S2 I-L). Host cell membrane
ruffling was restored when cells were infected with the
C. jejuni ciaD complemented isolate (Additional file 2:
Figure S2 M-P). While this experiment indicated that CiaD
is necessary for C. jejuni-induced membrane ruffling, it
was not clear if cortactin is required for membrane
ruffling.
Figure 4 Knockdown of endogenous cortactin and N-WASP prevent C. jejuni-invasion of INT 407 cells. A. Internalization of C. jejuni in INT
407 cells transfected with siRNA to cortactin, siRNA to N-WASP or a scrambled (Scram) siRNA. Results are shown as the mean number of internalized
bacteria ± SEM. B. Whole cell lysates of untreated, siRNA to cortactin, siRNA to N-WASP, and scramble siRNA-transfected cells were probed with
α-cortactin and α-N-WASP antibodies. The blot was re-probed with an α-tubulin antibody to confirm equal loading. C. Internalization of C. jejuni
in INT 407 cells transfected with phosphorylation null constructs of cortactin. Bacterial invasion was assessed using the gentamicin protection
assay. Results are displayed as mean number of internalized bacteria ± SEM. D. Whole cell lysates of untreated and cortactin phosphorylation null
transfected cells were collected and probed with an α-EGFP antibody. The blot was re-probed with an α-tubulin antibody to determine loading.
The asterisks indicate a significant difference (P < 0.01) compared to the value obtained for the C. jejuni wild-type strain, as judged by one-way
ANOVA followed by post-hoc Dunnett’s analysis. N.S. indicates no significant difference.
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phosphorylation of cortactin is necessary for C. jejuni-
induced membrane ruffling. INT 407 cells, which had
been transfected with cortactin-EGFP S405A, S418A, and
S405/418A phosphorylation null constructs, were infected
with a C. jejuni wild-type strain and evaluated by confocal
microscopy. Uninfected cells transfected with cortactin-
EGFP exhibited diffuse cortactin localization with no dis-
tinct membrane ruffling of the cell borders (Figure 5A-D).
Infection of cortactin-EGFP transfected cells with the
C. jejuni wild-type strain resulted in distinct membrane
ruffling (Figure 5E-H). C. jejuni infection of INT 407 cells
transfected with EGFP-cortactin S405A (Figure 5I-L),
S418A (Figure 5M-P), and S405/418A (Figure 5Q-T)
phosphorylation null constructs resulted in a diffuse
localization of cortactin and no observable membrane ruf-
fling in response to C. jejuni was observed. These resultsindicate that cortactin is required for C. jejuni-induced
membrane ruffling.
Scanning electron microscopy was performed to de-
termine the extent of C. jejuni-induced membrane ruf-
fling in cells transfected with siRNA to cortactin and
siRNA to N-WASP. More specifically, INT 407 cells
were transfected with a scrambled siRNA, siRNA to
cortactin, or siRNA to N-WASP, and infected with a
C. jejuni wild-type strain. INT 407 cells were also trans-
fected with cortactin-EGFP S405A, S418A, and S405/
418A phosphorylation null constructs. Representative
images of C. jejuni interaction with host cells are shown
in Figure 6A-P. We observed that 23.9% ± 8.6% of un-
treated and uninfected INT 407 cells had membrane ruf-
fling (Figure 6A). Membrane ruffling was observed in
69.6% ± 7.1% of the cells infected with a C. jejuni wild-
type strain (Figure 6B). Treatment of INT 407 cells with
Figure 5 Phosphorylation null constructs of cortactin prevent C. jejuni induced membrane ruffling. A-T. C. jejuni induced membrane ruffling is
impaired in INT 407 cells transfected with cortactin S405A, S418A or S405/418A phosphorylation null constructs. Representative confocal microscopy
images of INT 407 cells uninfected (Panel A-D) and cells infected with the C. jejuni wild-type strain with various treatment conditions. The panels
represent: Wild-type cortactin-EGFP (Panel E-H), cortactin S405A phosphorylation null construct (Panel I-L), cortactin S418A phosphorylation null
construct (Panel M-P), and cortactin S405/418A phosphorylation null construct (Panel Q-T). Images from left to right show, DAPI staining of cell
nuclei (Panels A, E, I, M, and Q), EGFP-cortactin (Panel B, F, J, N, and R), C. jejuni staining with a polyclonal rabbit α-Campylobacter antibody
and a secondary Texas-Red antibody (Panels C, G, K, O, and S), and merge of all panels (Panels D, H, L, P, and T). INT 407 cells that display extensive
membrane ruffling (Panel H), and cells that display no host cell membrane ruffling (Panels D, L, P, and T). C. jejuni in contact with the host cell is shown
in (Panels H-1, L-1, P-1, and T-1). Images were obtained with a 63× objective and have a 10 μM scale bar (Panels A-T). Arrows indicate
C. jejuni interaction with host cells. The areas within the box highlights regions of membrane ruffling and the areas within the circles indicate regions
of no membrane ruffling.
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C. jejuni resulted in levels of membrane ruffling similar
to untreated cells infected with C. jejuni (Figure 6C).
Treatment of host cells with siRNA to N-WASP and
siRNA to cortactin reduced membrane ruffling to 26.8% ±
6.0% and 27.9% ± 6.4%, respectively (Figure 6D and E). We
also observed a significant decrease in host cell membrane
ruffling when cells were transfected with phosphorylation
null constructs of cortactin (Figure 6F-H). Specifically, the
cortactin-EGFP S405A, S418A, and S405/418A phos-
phorylation null constructs reduced membrane ruffling
to 25.4% ± 4.2%, 28.6% ± 5.8%, and 31.5% ± 3.9%, re-
spectively. Noteworthy is that treatment of INT 407
cells with siRNA or phosphorylation null constructs pre-
vented membrane ruffling from occurring even in the
presence of direct bacterial contact (compare panels J
and K to panels L-P). These data indicate that cortactinand N-WASP are required for maximal membrane ruf-
fling induced by C. jejuni.
Cortactin, Erk 1/2, and N-WASP complex formation is CiaD
dependent
Immunoblot and immunoprecipitation (IP) experiments
were performed to determine if cortactin and Erk 1/2
are associated in response to C. jejuni infection. INT
407 cells were infected with C. jejuni for 45 minutes and
cortactin was precipitated using an α-cortactin antibody.
Infection of INT 407 cells with a C. jejuni wild-type strain
resulted in a significant increase (above uninfected cells)
in the amount of phosphorylated (activated) cortactin
(Figure 7). In contrast, the amount of activated cortactin
significantly decreased in INT 407 cells infected with the
C. jejuni ciaD mutant. Specifically, infection with the
C. jejuni wild-type strain and the ciaD complemented
Figure 6 Knockdown of endogenous cortactin and N-WASP prevent C. jejuni induced membrane ruffling. A-P. C. jejuni induced
membrane ruffling in INT 407 cells transfected with scrambled (Scram) siRNA, siRNA to N-WASP, siRNA to cortactin, and cortactin S405A, S418A
and S405/418A phosphorylation null constructs. Representative scanning electron microscopy images of INT 407 cells uninfected (Panel A) and
cells infected with C. jejuni wild-type strain with various treatment conditions; No treatment (Panel B), Scrambled siRNA control (Panel C), siRNA
to N-WASP (Panel D), siRNA to cortactin (Panel E), cortactin S405A (Panel F), cortactin S418A (Panel G), and cortactin S405/4118A (Panel H). Arrows
in the higher magnification images show C. jejuni in contact with host cells (Panels I-P). Boxes indicate the area of the INT 407 cell that is shown
in the 50,000× panel. INT 407 cells that display extensive membrane ruffling (Panel J and K), and INT 407 cells that display no host cell membrane
ruffling (Panels L-P). Images are shown at a magnification of 7,000× with a 10 μM scale bar (Panels A-H), and 50,000× with a 2 μM scale bar
(Panels I-P). Also indicated within each panel is the percent of host cell that display membrane ruffling.
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of activated cortactin, but the C. jejuni ciaD mutant
was indistinguishable from uninfected cells (Figure 7).
The association of Erk 1/2 and cortactin in cells infected
with the C. jejuni wild-type strain, ciaD mutant, and ciaD
complemented isolate was also determined by immuno-
precipitation. We found that CiaD is required for the
maximal association of cortactin with phosphorylatedErk 1/2 (Figure 7). The association of N-WASP with cor-
tactin was also determined to occur in a CiaD dependent
manner (Figure 7). This finding suggests that N-WASP
is associated with the serine phosphorylated form of
cortactin. Others have shown that serine phosphoryl-
ation of cortactin is necessary for N-WASP association
[36,38-40]. The IP experiments performed also revealed
that cortactin associates with phospho-Erk 1/2 and N-
Figure 7 CiaD is required for Erk 1/2-cortactin association. INT 407 cells were infected with a C. jejuni wild-type strain, ciaD mutant, ciaD
complemented isolate, or uninfected (control) for 45 min. A. The cell lysates were subjected to immunoprecipitation experiments with an
antibody against cortactin, separated by SDS-PAGE and blotted for cortactin, p-cortactin, N-WASP, and pErk 1/2. Whole cell lysates (WCL) were also
probed with an α-cortactin antibody to confirm similar inputs. Also shown are the blots of the IgG isotype control IP probed with cortactin, p-cortactin,
N-WASP and pErk 1/2 antibodies. B. Band intensity of p-cortactin, N-WASP, and pErk 1/2 were normalized to total cortactin from three independent
experiments. The asterisks indicate a significant difference (P < 0.01) compared to the value obtained for the C. jejuni wild-type strain, as judged by
one-way ANOVA followed by post-hoc Dunnett’s analysis. N.S. indicates no significant difference.
Samuelson and Konkel Cell Communication and Signaling 2013, 11:82 Page 10 of 15
http://www.biosignaling.com/content/11/1/82WASP upon C. jejuni infection, and that N-WASP and
phospho-Erk 1/2 association with cortactin is dependent
on CiaD (Figure 7). These data show that C. jejuni induces
the formation of the actin nucleation and polymerization
complex Erk 1/2-cortactin-N-WASP, and that this associ-
ation is, in part, dependent of the C. jejuni effector protein
CiaD. These data also show that the recruitment of
N-WASP to cortactin requires Erk 1/2 serine phosphoryl-
ation of cortactin.
Discussion
This study was performed to further elucidate the mechan-
ism of C. jejuni invasion of host cells. More specifically, we
investigated the role of Erk 1/2 and cortactin in C. jejuni
invasion of host cells. Erk 1/2 is a serine/threonine kinase
that is part of the Ras-Raf-MEK-ERK signal transductioncascade. Erk 1/2 is activated by dual phosphorylation at
Y204/187 and T202/185 catalyzed by MEK 1/2 [41,42].
Erk 1/2 catalyzes the phosphorylation of hundreds of
cytoplasmic and nuclear proteins and participates in
numerous cellular processes including cell adhesion, cell
cycle progression, cell migration, cell survival, differen-
tiation, metabolism, proliferation, and transcription [42].
Cortactin is a filamentous actin binding protein that is
a crucial link between the organization of structural
proteins, such as actin, and cellular signal transduction
pathways. Cortactin stimulates actin polymerization via
interaction with N-WASP through its SH3 domain, and
binding of Arp 2/3 through its N-terminal domain [36].
Cortactin is regulated by phosphorylation of Y421,
Y470, and Y486 by c-Src and other tyrosine kinases
[36]. Likewise, Erk 1/2 phosphorylates S405 and S418
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phosphorylates cortactin, however the implications of
PAK serine phosphorylation are poorly defined [1,36].
Work by Martinez-Quiles et al. (2004) revealed that phos-
phorylation of cortactin by Erk 1/2 acts as a positive regu-
latory event and Src phosphorylation acts as a negative
regulatory event in actin cytoskeletal rearrangement by ac-
tivation/deactivation of N-WASP and Arp2/3 [40]. Add-
itionally, Kelley et al. [39] demonstrated that concurrent
phosphorylation of cortactin by Erk 1/2 and tyrosine ki-
nases allow cells to regulate actin dynamics through N-
WASP. Taken together, it is clear that the activation and
deactivation of cortactin by phosphorylation is a dynamic
process. In the present study, we showed that phosphoryl-
ation of cortactin on S405, S418, Y421, Y470, and Y486
are required for maximal invasion of host cells by C.
jejuni. Specifically, we show that CiaD is required for max-
imal activation of Erk 1/2 (Figure 1). Activation of Erk 1/2
leads to the phosphorylation of S405 and S418 on
cortactin (Figure 3). Also, the association of cortactinFigure 8 Model of C. jejuni internalization. C. jejuni invasion of host cells.
proteins CadF (blue dots) and FlpA (yellow dots) [43,44] causing activation o
(EGFR) [27,45]. Step 2: Activation of the α5β1 integrin leads to the recruitmen
of the Campylobacter invasion antigens (e.g., CiaD shown in red) to the host
the focal complex (i.e., FAK, paxillin, vinculin, p130Cas, Src, and the CrkII/DOC
by Campylobacter jejuni is independent of caveolin-1, In Submission]. Ste
phosphorylation of Erk 1/2. Caveolin-1, Vav2, Rac1, and Cdc42 are also activated
and Src leads to the phosphorylation of cortactin, which allows for the Rho GT
cortactin, promoting actin cytoskeletal reorganization. Highlighted in this mode
for the maximal activation of the Erk 1/2 and cortactin signaling pathways. Com
shown in blue. The newly identified components of the C. jejuni invasion compwith Erk 1/2 is dependent on CiaD (Figure 7). Further-
more, we found that serine phosphorylation of cortactin is
required for maximal C. jejuni induced host cell membrane
ruffling. These findings provide the basis for a detailed
model of C. jejuni invasion of host cells (Figure 8).
Previous work has shown that Dock180 and its bind-
ing partner ELMO (Engulfment and Cell Motility) form
a bipartite guanine nucleotide exchange factor (GEF),
resulting in the activation of Rac1 and membrane ruf-
fling [27]. C. jejuni invasion of cells is also accompanied
by the activation of Cdc42 [28,45]. Interestingly, several
effector proteins from Salmonella enterica, including
SopE, SopE2 and SopB, modulate the activity of Cdc42
and Rac1 to manipulate actin cytoskeleton rearrange-
ments [48,49]. Noteworthy is that the IcsA effector
protein from Shigella flexneri promotes filopodia forma-
tion by binding and activating N-WASP in a Cdc42-like
fashion [50]. To determine the role of CiaD in C. jejuni in-
vasion of host cells, we first evaluated the Rho GTPases
Rac1 and Cdc42 as a loss in the activation of eitherStep 1: C. jejuni binds to fibronectin (Fn) via the two C. jejuni Fn binding
f the α5β1 integrin receptors and the epidermal growth factor receptor
t and partial activation of FAK and paxillin [27,46]. Step 3: The delivery
cell [16,19,27,47] leads to the maximal activation of key components of
K-180/ELMO complex) [27,28,45, Konkel et. al, Invasion of epithelial cells
p 4: Focal complex activation, in conjunction with CiaD, leads to the
following focal complex activation [27,28,45]. Step 5: Activation of Erk 1/2
Pases Rac1 and Cdc42 to activate N-WASP associated with phosphorylated
l is the role of CiaD in C. jejuni internalization. Specifically, CiaD is necessary
ponents of the focal complex and focal complex associated proteins are
lex are shown in green.
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mutant. INT 407 cells infected with the C. jejuni ciaD
mutant exhibited levels of Rho GTPase activation similar
to that of cells infected with the C. jejuni wild-type strain.
This is in stark contrast to cells infected with a C. jejuni
ciaC mutant that display a significant reduction in Rac1
activation [27]. The reduction in Rac1 activity with the C.
jejuni ciaC mutant is in agreement with the fact that
there are fewer sites of co-localized Rac1 in INT 407
cells infected with the C. jejuni ciaC mutant versus a C.
jejuni wild-type strain [27]. Our data supports the pro-
posal that CiaD is manipulating cellular signaling cascades
and altering actin nucleation at a site downstream from
Rac1 and Cdc42. Moreover, our results indicate that CiaC
and CiaD manipulate at least two distinct host cell targets
that are necessary for C. jejuni invasion of host cells.
Based on the observation that Erk 1/2 is critical for
C. jejuni invasion of host cells, we performed experiments
to determine if: 1) Erk 1/2 is transcriptionally regulating
cellular components involved in cell invasion; and/or 2)
Erk 1/2 is necessary for the activation of cytosolic cellular
signaling cascades involved in cytoskeleton rearrangement.
We found that the transcription of the gene that encodes
for IL-8 is not required for invasion, but that Erk 1/2 is re-
quired for the serine phosphorylation of cortactin. As pre-
viously stated, cortactin is an actin-binding protein that
recruits N-WASP and activates Arp 2/3, leading to actin
remodeling [36]. Interestingly, Erk 1/2 activation stimu-
lates bacterial capture of Shigella by filopodia [51], while
the OspF effector protein from Shigella harbors phosphat-
ase activity to inactivate mitogen-activated protein kinases
(MAPKs), including Erk 1/2, c-Jun N-terminal kinase, and
p38, post-invasion [52]. Collectively, these data highlight
the fact that Erk 1/2 is a key component of the C. jejuni
invasion complex and that bacterial pathogens can ma-
nipulate membrane extensions (e.g., lamellipodia and filo-
podia) by targeting Erk 1/2.
Cortactin is likely involved in the uptake of patho-
genic bacteria into host cells, as it acts in concert with
N-WASP to activate the Arp2/3 complex. It is plausible
for a pathogen to activate cortactin directly or to acti-
vate cortactin indirectly via Erk 1/2 or Src. For example,
the IpaC effector protein from Shigella mediates Src-
dependent phosphorylation of cortactin, thereby pro-
moting actin polymerization [53]. We found that serine
phosphorylation of cortactin by C. jejuni is dependent
upon Erk 1/2, as the level of phospho-cortactin in C. jejuni
infected cells treated with the PD98059 inhibitor was indis-
tinguishable from uninfected cells.
Here we demonstrate that the formation of the Erk 1/2-
cortactin-N-WASP complex is dependent on the C. jejuni
effector protein CiaD. To our knowledge this is the first re-
port of the involvement of cortactin and N-WASP in host
cell invasion by C. jejuni. In addition, this is the first reportshowing that Erk 1/2 mediated serine phosphorylation of
cortactin is required for C. jejuni invasion of host cells. Fu-
ture studies will focus on the identification of the direct
target of CiaD and the kinetics and regulation of cortactin
in bacterial invasion. This work provides new insight into
C. jejuni pathogenesis and the complex signaling events
exploited by bacterial pathogens during the process of
invasion. Equally important, it contributes to the un-
derstanding of the phosphorylation of cortactin in bac-
terial infection.
Conclusion
In this study, we present a model for C. jejuni invasion
of host cells (Figure 8). We show that C. jejuni acti-
vates Erk 1/2. Specifically, we found that Erk 1/2 activa-
tion is dependent on the C. jejuni effector protein CiaD.
Similarly, we found that Erk 1/2 activation is necessary
for bacterial invasion because it is necessary for the phos-
phorylation of serine residues in cortactin. Moreover, in-
hibition of serine phosphorylation results in decreased
bacterial invasion and host cell membrane ruffling. The
requirement of serine phosphorylation of cortactin by
Erk 1/2 in C. jejuni host cell invasion represents a mech-
anistic basis for how Erk 1/2 inhibition leads to impaired
C. jejuni invasion.
Methods
Bacterial strains, tissues culture types
The Campylobacter jejuni F38011 clinical isolate was used
in this study. All C. jejuni isolates were cultured on
Muller-Hinton agar plates containing bovine citrated blood
(MHB) with the appropriate antibiotic at the following final
concentrations: chloramphenicol 8 microgram/mL and
tetracycline 2 microgram/mL. Cultures were grown at 37°
C in a microaerobic chamber (5% O2, 10% CO2, and 85%
N2). INT 407 cells (ATCC CCL 6) were obtained form the
American Type Culture Collection (ATCC). INT 407 cells
were cultured in minimal essential medium (MEM) sup-
plemented with 10 mM sodium pyruvate, 20 mM glutam-
ine, and 10% (v/v) fetal bovine serum (FBS).
Preparation of INT 407 whole cell lysates
Whole cell lysates (WCL) of INT 407 cells were pre-
pared by the addition of lysis buffer, as described previ-
ously [27]. The lysates were collected and analyzed by
SDS-PAGE coupled with immunoblot analyses. The pro-
tein concentration of each sample was determined by the
bicinchoninic acid (BCA, Pierce, Rockford, IL) protein
assay and normalized prior to SDS-PAGE.
Immunoblot analysis, cellular inhibitors, antibodies,
and densitometry analysis
Immunoblots were performed as described previously
[27]. INT 407 cell lysates were collected and analyzed by
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were transferred to a polyvinylidene fluoride (PVDF) mem-
brane, and probed with the indicated antibodies. Primary
antibodies reactive against N-WASP (Cell Signaling
Technology, Cat # 4848), phospho-Erk 1/2 (Cell Signaling
Technology, Cat # 4377), total-Erk 1/2 (Santa Cruz,
Dallas, TX, Cat # sc-94) cortactin (Cell Signaling Tech-
nology, Cat # 3503), phospho-cortactin (S418) (Protea,
Morgantown, WV, Cat # AB-110), phospho-cortactin
(S405) (Protea Biosciences, Inc., Morgantown, WV, Cat #
AB-100), tyrosine-phospho-cortactin (Millipore, Billerica,
MA, Cat # 05–180) and tubulin (Sigma, Cat # T6199) were
used at a 1:1000 dilution and incubated overnight at 4°C.
The α-rabbit IgG or the α-mouse IgG (Sigma, St. Louis,
MO) secondary antibodies were applied at a 1:2000 dilu-
tion for 1 h at room temperature. Band intensity was
quantified using a LAS 4000 mini (GE healthcare) and the
Multi Gauge V3.0 (Fujifilm, Valhalla, NY) software pack-
age. Densitometry analysis is shown as the ratio of
phosphoprotein to total protein (i.e., p-Erk 1/2 to total Erk
1/2 and p-cortactin to total cortactin) or as the ratio of
target protein to cortactin in the IP experiments (i.e., N-
WASP to total cortactin and p-Erk 1/2 to total cortactin).
Inhibitors or vehicle [dimethyl sulfoxide (DMSO)] were
added to INT 407 cells 30 min prior to infection and
maintained throughout the assay. The Erk 1/2 inhibitor
PD98059 (Selleck, Houston, TX, Cat # S1177) was used at
50 μM. The c-Src inhibitor PP2 (Sigma, Cat # P0042) was
used at 5, 10, 20, and 40 μg/mL. The transcription inhibitor
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)
(Sigma, Cat # D1916) was used at 10, 20, and 40 μM. Cell
death was quantified with trypan blue staining. No signifi-
cant death of INT 407 cells was observed with any of the
treatments (not shown).
Binding and internalization assays
Binding and internalization assays were performed as
described elsewhere [27]. INT 407 cells were seeded at a
density of 1.5 × 105 into 24-well flat bottom tissue cul-
ture trays (BD Falcon, Franklin Lakes, NJ, Cat # 353047).
Bacteria were suspended in MEM containing 1% FBS
and added to cells at a multiplicity of infection (MOI) of
100. Trays were centrifuged at 800 × g to promote bacterial
cell contact. Cells were lysed with 0.1% Triton-X100 and
plated onto MHB agar for bacterial enumeration. C. jejuni
host cell invasion was assessed by lysing INT 407 cells and
enumerating the internalized bacteria following a 3 h incu-
bation with 250 microgram/mL of gentamicin.
Transfection of phosphorylation null constructs
Human Cortactin-GFP and S405A, S418A, S405/S418A,
Y421F, and Y421/470/486F phosphorylation null GFP
constructs of cortactin were generously provided by
Dr. Scott Weed from West Virginia University [38].Plasmids were purified using the Qiagen Plasmid Purifi-
cation Kit (Qiagen, Valencia, CA) according to the manu-
facturer’s protocols. Purified plasmids were quantified
using NanoDrop 2000c (Thermo Scientific, Wilmington,
DE) and normalized to 200 ng/μl. Purified plasmids where
transfected into INT 407 cells seeded on glass coverslips
at 3 × 105. Transfections where performed using the
Qiagen Effectene Transfection reagent (Qiagen, Valencia,
CA), according to the manufacturer’s specifications.Confocal microscopy
INT 407 cells were infected with C. jejuni for 45 min at
37°C in a 5% CO2 incubator prior to fixation with 3.7%
paraformaldehyde for 15 min. C. jejuni were stained
with a 1° rabbit α-C. jejuni antibody (Konkel Labora-
tory Collection) and a 2° Texas Red dye-conjugated
donkey α-rabbit antibody (Jackson ImmunoResearch
Labs, West Groves, PA). The coverslips were mounted
with VectaShield and 4′,6-diamidino-2-phenylindole
(DAPI, Vector Laboratories, Burlingame, CA) added to
stain DNA. Images were obtained using a Zeiss con-
focal microscope using a 63X, 1.4 NA water immersion
objective lens.Scanning electron microscopy
Scanning electron microscopy was performed as de-
scribed elsewhere [27]. INT 407 cells were transfected
with the phosphorylation null or siRNA constructs.
C. jejuni was added to cells for 15 minutes. Quantification
of membrane ruffling was done by two independent ob-
servers and tabulated. Cells were counted and cells positive
for membrane ruffling were scored.Treatment of cells with small interfering RNA (siRNA)
INT 407 cells were transfected with siRNA using lipofecta-
mine RNAiMAX (Invitrogen, Grand Island, NY) according
to the manufacturer’s instructions. Cortactin stealth siRNA
(Invitrogen, Grand Island, NY, Cat # S4665), N-WASP
stealth siRNA (Invitrogen, Cat # S17132), and scrambled
control siRNA (Invitrogen, Cat # 46–2000) were applied to
the cells 24 h prior to infection. Knockdown of endogen-
ous proteins were confirmed by immunoblot.Assessment of Rho GTPase Rac1 and Cdc42 activation
INT 407 cells were seeded into 6-well tissue culture
trays at a density of 2 × 105 cells/well and serum starved
for 24 h. C. jejuni was resuspended in PBS and added to
the cells. The amount of activated Rac1 and Cdc42 in
C. jejuni-infected and uninfected cells was determined
using the G-LISA™ Rac1 and Cdc42 Activation Assays ac-
cording to the manufacturer’s instructions (Cytoskeleton,
Denver, CO).
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INT 407 cells were seeded at 3 × 106 cells per dish and
serum starved in MEM for 3 h prior to the addition of
C. jejuni or the uninfected (negative control). Forty-five
min post-infection, cells were collected in ice-cold lysis
buffer as described previously [27]. Immunoprecipita-
tions were performed by incubating cell lysates with an
α-cortactin antibody (Cell Signaling Technology, Inc.,
Danvers, MA) at 4°C overnight and then adding protein
A/G beads at 4°C for 1 h with rotation. The bead com-
plexes were washed and dissolved in sample buffer.
IL-8 quantification
Interleukin-8 levels in cellular supernatants were quantified
with a commercial ELISA (OptEIA Set, Becton Dickinson,
Cowley, Oxford, UK) using the manufacturer’s protocol.
INT 407 cells were pre-treated with DRB as described
above and inoculated with C. jejuni. Cells were centrifuged
for 5 min at 800 × g to promote cell contact. The cells were
incubated at 37°C for 6 h and the media were collected
from each well. Supernatants were used immediately or
frozen at −20°C.
Statistical analysis
All data were evaluated using one-way ANOVA followed
by post-hoc Tukey’s or Dunnet’s analysis of the means,
using Prism 6 (GraphPad Software, La Jolla, CA). Statis-
tical significance was defined by a maximum value of
*P < 0.05. All experiments were performed a minimum of
three times to ensure reproducibility.
Additional files
Additional file 1: Figure S1. Inhibition of c-Src prevents C. jejuni invasion
of INT 407 cells. Internalization of C. jejuni by INT 407 cells treated or untreated
(control) with the c-Src inhibitor PP2 for 30 min prior to bacterial invasion.
Bars represent the mean number of internalized bacteria ± SEM. The aster-
isks indicate a significant difference (P < 0.01) compared to the value ob-
tained for the C. jejuni wild-type strain, as judged by one-way ANOVA
followed by post-hoc Dunnett’s analysis.
Additional file 2: Figure S2. CiaD is required for membrane ruffling.
A-P. CiaD is required for C. jejuni induced membrane ruffling in INT
407 cells transfected with cortactin-EGFP. Representative confocal
microscopy images of INT 407 cells uninfected (Panel A-D) and infected
with a C. jejuni wild-type strain (Panel E-H), a ciaD mutant (Panel I-L), and a
ciaD complemented isolate (Panel M-P). Images from left to right show,
DAPI staining of cell nuclei (Panels A, E, I, and M), EGFP-cortactin (Panel B,
F, J, and N), C. jejuni staining with a polyclonal rabbit α-Campylobacter
antibody and a secondary Texas-Red (Panels C, G, K, and O), and merge of
all panels (Panels D, H, L, and P). C. jejuni in contact with the host cell is
shown in Panels H-1, L-1, and P-1. Images were taken with a 63× objective
and have a 10 μM scale bar (Panels A-P). Arrows indicate C. jejuni interaction
with host cells. The areas within the boxes highlight regions of membrane
ruffling (Panels F and N) and the areas within the circles indicate regions of
no membrane ruffling (Panels B and J).
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